APYX vs. NNOX, ZIMV, SNWV, CATX, NYXH, DRTS, SMTI, BWAY, SKIN, and TCMD
Should you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Nano-X Imaging (NNOX), ZimVie (ZIMV), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Sanara MedTech (SMTI), Brainsway (BWAY), Beauty Health (SKIN), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.
Apyx Medical vs. Its Competitors
Apyx Medical (NASDAQ:APYX) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.
In the previous week, Apyx Medical had 2 more articles in the media than Nano-X Imaging. MarketBeat recorded 2 mentions for Apyx Medical and 0 mentions for Nano-X Imaging. Apyx Medical's average media sentiment score of 0.00 equaled Nano-X Imaging'saverage media sentiment score.
55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 15.2% of Apyx Medical shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Nano-X Imaging has a consensus price target of $9.50, indicating a potential upside of 83.40%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Apyx Medical.
Apyx Medical has a net margin of -42.37% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat Apyx Medical's return on equity.
Apyx Medical has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.
Apyx Medical has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500.
Summary
Apyx Medical beats Nano-X Imaging on 9 of the 16 factors compared between the two stocks.
Get Apyx Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Apyx Medical Competitors List
Related Companies and Tools
This page (NASDAQ:APYX) was last updated on 7/10/2025 by MarketBeat.com Staff
